REGENXBIO Inc. 4
4 · REGENXBIO Inc. · Filed Jun 2, 2016
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Samuels Camille D
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-06-01+12,500→ 12,500 totalExercise: $12.74Exp: 2026-06-01→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]The option will vest in twelve (12) equal monthly installments following June 1, 2016.
- [F2]Under an agreement between the reporting person and VR Management, LLC (the "Management Company"), the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the indirect beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.